Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05058950 · ClinicalTrials.gov registry record
An Observational Study Using Multimodal Sensors to Measure Cognitive Health in Adults and Distinguish Mild Cognitive Impairment From Normal Aging
A clinical trial, sponsored by Biogen.
- Terminated
- Registry status
- 22,720
- Enrollment target
NCT05058950 is a clinical trial that was terminated before completion, run by Biogen. The registered enrollment target is 22,720 participants.
The verdict
NCT05058950 was terminated before completion, sponsored by Biogen.
- TERMINATED
- Registry status
- 22,720 participants
- Enrollment target
Study Summary
The primary objectives are to develop and validate a classifier using multimodal passive sensor data and metrics derived from normal iPhone and Apple Watch usage to distinguish individuals with normal cognition from those with mild cognitive impairment (MCI) and to develop and validate a cognitive wellness score that tracks fluctuations in cognitive performance over time using multimodal passive sensor data and metrics derived from normal iPhone and Apple Watch usage.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22,720 participants |
| Start Date | 2021-09-20 |
| Est. Completion | 2023-09-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05058950
The ClinicalTrials.gov registry entry for NCT05058950 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 22,720 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05058950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05058950 about?
NCT05058950 is a clinical study titled "An Observational Study Using Multimodal Sensors to Measure Cognitive Health in Adults and Distinguish Mild Cognitive Impairment From Normal Aging". The primary objectives are to develop and validate a classifier using multimodal passive sensor data and metrics derived from normal iPhone and Apple Watch usage to distinguish individuals with normal cognition from those with mild cognitive impairment (MCI) and to develop and validate a cognitive w...
What is the current status of trial NCT05058950?
This trial is currently terminated. The enrollment target is 22,720 participants. The study started on 2021-09-20. Estimated completion is 2023-09-19.
Who is sponsoring clinical trial NCT05058950?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.